As pharma companies bolster their pipelines via multibillion-dollar acquisitions, drug manufacturers continue to heavily invest in the oncology space.

A U.S. Senate panel on Wednesday launched a bipartisan probe into pharmaceutical drug pricing, seeking documents from four drugmakers including Valeant Pharmaceuticals and Turing Pharmaceuticals, two companies embroiled in controversy over price hikes on lifesaving drugs.   The Senate’s Special Committee on Aging also requested information from Retrophin Inc and Rodelis Therapeutics, according to a […]